FDA approves opioid-free pain medication with 'no sign of addiction'
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Dr. Gupta details new FDA-approved pain medication with no opioids
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
‘There has never been a more dangerous time to take drugs’: the rising global threat of nitazenes and synthetic opioids
Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are ...
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
aha.org6d
FDA approves first-in-class non-opioid painkiller
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
Fox News5d
FDA approves opioid-free pain medication with 'no sign of addiction'
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...
Gizmodo6d
No Opioids, No Addiction: FDA Approves First New Type of Painkiller in Decades
To treat acute pain, doctors in the U.S. commonly prescribe opioids: powerful painkillers with dangerous side effects including serious risk of addiction and overdose. Now, the U.S. Food and Drug ...
CenExel Celebrates FDA Approval of JOURNAVX(TM), a Groundbreaking Non-Opioid Pain Treatment
CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...